Judge rejects AstraZeneca's challenge to Medicare drug price negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC.A federal judge on Friday rejected AstraZeneca's legal challenge to Medicare's new power to negotiate the prices of certain costly prescription drugs with manufacturers.The decision is another win for the Biden administration in a bitter legal fight with the pharmaceutical industry over the constitutionality of those price talks. The negotia ...